Product Information
METRONIDAZOLE TOPICAL 0.75% GL is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.2209 per GM under NDC 51672411606. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 18, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/g
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672411606
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA077819FDA Approved
7/18/2006
TE Code
AB
On Market Since
7/18/2006
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE TOPICAL 0.75% GL has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 91.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2209 per GM |
|---|---|
| All-time high | $2.7335 (Feb 12, 2014) |
| All-time low | $0.2209 (Aug 19, 2026) |
| 52-week high | $0.4207 |
| 52-week low | $0.2209 |
| Median price | $0.9393 |
| Average price | $1.1537 |
| Largest weekly change | +29.4% (Oct 23, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METRONIDAZOLE TOPICAL 0.75% GL?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE TOPICAL 0.75% GL, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.2209 per GM (NDC 51672411606), effective Aug 19, 2026.
How has the price of METRONIDAZOLE TOPICAL 0.75% GL changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE TOPICAL 0.75% GL has declined 91.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE TOPICAL 0.75% GL?
Since Nov 28, 2013, the NADAC for METRONIDAZOLE TOPICAL 0.75% GL has ranged from a low of $0.2209 (Aug 19, 2026) to a high of $2.7335 (Feb 12, 2014), with a median of $0.9393 per GM.
Are there cheaper alternatives to METRONIDAZOLE TOPICAL 0.75% GL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE VAGINAL 0.75% GL, is $0.1413 per GM — about 36% below METRONIDAZOLE TOPICAL 0.75% GL.
Who manufactures METRONIDAZOLE TOPICAL 0.75% GL?
METRONIDAZOLE TOPICAL 0.75% GL (NDC 51672411606) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.